← FDA DRUG APPROVALS

FDA ANDA · ANDA086833

CYPROHEPTADINE HYDROCHLORIDE

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA086833
TYPE
ANDA
ORIGINAL APPROVAL
1980-04-16
LATEST ACTION
2000-10-02
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

CYPROHEPTADINE HYDROCHLORIDE · ReferenceDiscontinued
CYPROHEPTADINE HYDROCHLORIDE 2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SYRUP · ORAL

Approval history

2000-10-02Manufacturing (CMC) · Supplement 27AP
1997-09-29Labeling · Supplement 25AP
1990-09-28Manufacturing (CMC) · Supplement 24AP
1990-04-05Labeling · Supplement 22AP
1989-12-26Labeling · Supplement 21AP
1989-11-06Labeling · Supplement 16AP
1989-10-11Labeling · Supplement 20AP
1989-03-03Manufacturing (CMC) · Supplement 18AP
1989-03-03Manufacturing (CMC) · Supplement 19AP
1989-03-03Manufacturing (CMC) · Supplement 17AP
1986-11-05Manufacturing (CMC) · Supplement 15AP
1983-04-11Manufacturing (CMC) · Supplement 12AP
1982-11-26Manufacturing (CMC) · Supplement 11AP
1982-11-22Manufacturing (CMC) · Supplement 10AP
1980-04-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →